Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

By Hancock G.E.   Speelman D.J.   Frenchick P.J.   Mineo-Kuhn M.M.   Baggs R.B.   Hahn D.J.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 391-400

Elsevier

Access to resources Recommend Favorite

CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice

By Harcourt J.L.   Brown M.P.   Anderson L.J.   Tripp R.A.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2964-2979

Elsevier

Access to resources Recommend Favorite

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

By Neuzil K.M.   Johnson J.E.   Tang Y.-W.   Prieels J.-P.   Slaoui M.   Gar N.   Graham B.S.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 525-532

Elsevier

Access to resources Recommend Favorite

Intranasal IFN- gene transfer protects BALB/c mice against respiratory syncytial virus infection

By Kumar M.   Behera A.K.   Matsuse H.   Lockey R.F.   Mohapatra S.S.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 558-567

Elsevier

Access to resources Recommend Favorite

Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice

By Turnbull T.   Toms G.L.   Scott R.   Bright H.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 915-922

Elsevier

Access to resources Recommend Favorite